Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers.

PURPOSE A real-time tracking radiotherapy was investigated to assess its usefulness in precise localization and verification of prostate and bladder cancers. METHODS AND MATERIALS The real-time tracking radiation therapy (RTRT) system consists of implantation of a 2.0-mm gold marker into a clinical target volume (CTV), three-dimensional radiation treatment planning (3DRTP) system, and the use of two sets of diagnostic x-ray television systems in the linear accelerator room, image processing units, and an image display unit. The position of the patient can be corrected by adjusting the actual marker position to the planned marker position, which has been transferred from the 3DRTP and superimposed on the fluoroscopic image on the display unit of the RTRT system. The position of the markers can be visualized during irradiation and after treatment delivery to verify the accuracy of the localization. Ten patients with prostate cancer and 5 patients with bladder cancer were examined using this system for the treatment setup on 91 occasions. RESULTS After manual setup using skin markers, the median of absolute value of discrepancies between the actual position of the marker and the planned position of the marker for prostate cancer was 3.4 (0.1-8.9) mm, 4.1 (0.2-18.1) mm, and 2.3 (0.0-10.6) mm for the lateral, anteroposterior, and craniocaudal directions, respectively. The 3D median distance between the actual and planned positions of the marker was 6.9 (1.1-18.2) mm for prostate cancer and 6.9 (1.7-18.6) mm for bladder cancer. After relocation using RTRT, the 3D distance between the actual and planned position of the marker was 0.9 +/- 0.9 mm. Median 3D distances between actual positions after treatment delivery and planned positions were 1.6 (0.0-6.3) mm and 2.0 (0.5-8.0) mm during daily radiotherapy for the marker in patients with prostate cancer and bladder cancer, respectively. CONCLUSION We believe the new positioning system can reduce uncertainty due to setup error and internal organ motion, although further improvement is needed for the system to account for the rotational and elastic changes of the affected tissues.

[1]  M. Zelefsky,et al.  Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma , 1999, Cancer.

[2]  M van Herk,et al.  Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. , 1995, International journal of radiation oncology, biology, physics.

[3]  D P Dearnaley,et al.  Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. , 1999, International journal of radiation oncology, biology, physics.

[4]  A. Hart,et al.  Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  P. Bergström,et al.  High-precision conformal radiotherapy (HPCRT) of prostate cancer--a new technique for exact positioning of the prostate at the time of treatment. , 1998, International journal of radiation oncology, biology, physics.

[6]  D P Dearnaley,et al.  Portal imaging protocol for radical dose-escalated radiotherapy treatment of prostate cancer. , 1998, International journal of radiation oncology, biology, physics.

[7]  T E Schultheiss,et al.  A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[8]  V. Althof,et al.  Variation in prostate position relative to adjacent bony anatomy. , 1996, International journal of radiation oncology, biology, physics.

[9]  M Wannenmacher,et al.  Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. , 1996, International journal of radiation oncology, biology, physics.

[10]  J. Crook,et al.  Prostate motion during standard radiotherapy as assessed by fiducial markers. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  D A Jaffray,et al.  Managing geometric uncertainty in conformal intensity-modulated radiation therapy. , 1999, Seminars in radiation oncology.

[12]  G J Kutcher,et al.  Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[13]  T E Schultheiss,et al.  Daily CT localization for correcting portal errors in the treatment of prostate cancer. , 1998, International journal of radiation oncology, biology, physics.

[14]  M. V. van Herk,et al.  Physical aspects of a real-time tumor-tracking system for gated radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[15]  Shinichi Shimizu,et al.  Real-time tumour-tracking radiotherapy , 1999, The Lancet.

[16]  T W Griffin,et al.  Reduction of radioactive seed embolization to the lung following prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[17]  K Lam,et al.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers. , 1995, International journal of radiation oncology, biology, physics.